Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “IgA Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03410290
What this trial is testing

Journey of Patients With Vasculitis From First Symptom to Diagnosis

Who this might be right for
VasculitisSystemic VasculitisBehcet's Disease+13 more
University of Pennsylvania 456
Testing effectiveness (Phase 2)Looking for participantsNCT07375758
What this trial is testing

MIL116 in Healthy Participants and Patients With IgA Nephropathy.

Who this might be right for
Immunoglobulin A Nephropathy
Beijing Mabworks Biotech Co., Ltd. 130
Post-approval studies (Phase 4)Not Yet RecruitingNCT07820995
What this trial is testing

Mechanistic Evaluation of Atrasentan in Patients With IgA Nephropathy (IgAN)

Who this might be right for
IgA Nephropathy (IgAN)Immunoglobulin A Nephropathy (IgAN)
University of Illinois at Chicago 20
Not applicableStudy completedNCT02912520
What this trial is testing

Comparison of IgA Levels in the Bronchoalveolar Lavage Fluid of Patients With and Without Antibiotic Therapy

Who this might be right for
Immunoglobulin A
Medical University of Vienna 20
Testing effectiveness (Phase 2)Study completedNCT00446251
What this trial is testing

Effects of Rituximab and Mycophenolate Mofetil (MMF) on Highly Sensitized Patients Awaiting Renal Transplant

Who this might be right for
Kidney Failure, ChronicDiabetic NephropathiesGlomerulonephritis, IGA+1 more
University of Washington 14
Not applicableStudy completedNCT04004390
What this trial is testing

Treatment of Post-poliomyelitis Syndrome by Intravenous Immunoglobulin

Who this might be right for
Post-Poliomyélitis Syndrom
University Hospital, Montpellier 17
Large-scale testing (Phase 3)Active Not RecruitingNCT05797610
What this trial is testing

Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression

Who this might be right for
Primary IgA Nephropathy
Hoffmann-La Roche 459
Post-approval studies (Phase 4)Study completedNCT04525729
What this trial is testing

Rituximab and RASi in Patients with IgAN

Who this might be right for
IgA Nephropathy
Nan Chen,MD 116
Large-scale testing (Phase 3)UnknownNCT02662283
What this trial is testing

Validity and Security of Reh-acteoside Therapy for Patients of IgA Nephropathy

Who this might be right for
IGA Nephropathy
Sun Yat-sen University 75
Post-approval studies (Phase 4)Study completedNCT00150059
What this trial is testing

Efficacy and Safety of Pimecrolimus Cream 1% in Patients ≥ 3 Months of Age With Mild or Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Novartis
Testing effectiveness (Phase 2)Study completedNCT00006184
What this trial is testing

Chemotherapy, Stem Cell Transplantation and Donor and Patient Vaccination for Treatment of Multiple Myeloma

Who this might be right for
Multiple Myeloma
National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07553494
What this trial is testing

SLN12140 in Adult Participants With IgA Nephropathy in China

Who this might be right for
IgA Nephropathy (IgAN)
Linno Pharmaceuticals, Inc. 48
Not applicableUnknownNCT01203007
What this trial is testing

Diet Intervention in Food Sensitive Patients With IgA Nephropathy

Who this might be right for
IGA Nephropathy
Uppsala University Hospital 40
Post-approval studies (Phase 4)Looking for participantsNCT06712407
What this trial is testing

Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy

Who this might be right for
IgA Nephropathy
Calliditas Therapeutics AB 60
Not applicableLooking for participantsNCT05036850
What this trial is testing

China Kidney Patient Trials Network

Who this might be right for
Kidney Diseases
George (Beijing) Clinical Research Co. Ltd. 1,200
Testing effectiveness (Phase 2)Ended earlyNCT04042623
What this trial is testing

Study of Safety and Efficacy of AVB-S6-500 in Patients With IgA Nephropathy

Who this might be right for
IgA Nephropathy
Aravive, Inc. 1
Post-approval studies (Phase 4)Looking for participantsNCT07030894
What this trial is testing

Nefecon and Ambrisentan in IgA Nephropathy

Who this might be right for
IgA NephropathyChronic Kidney DiseaseProteinuria
The First Hospital of Jilin University 129
Large-scale testing (Phase 3)Study completedNCT02298062
What this trial is testing

Infliximab for Kawasaki Disease Patients Resistant to IVIG : a Multicentre, Prospective, Randomised Trial

Who this might be right for
Kawasaki Disease
Fudan University 40
Very early researchNot Yet RecruitingNCT06690359
What this trial is testing

IM19 CAR-T Cell Therapy for IgA Nephropathy Patients and Membranous Nephropathy Patients

Who this might be right for
IgA NephropathyMembranous Nephropathy
Beijing Immunochina Medical Science & Technology Co., Ltd. 12
Testing effectiveness (Phase 2)Ended earlyNCT05847920
What this trial is testing

Efficacy and Safety of SHR-2010 Injection in the Treatment of Primary IgA Nephropathy

Who this might be right for
Primary IgA Nephropathy
Guangdong Hengrui Pharmaceutical Co., Ltd 53
Next Page